IMVARIA
Medical and Diagnostic Laboratories
Berkeley, CA501 followers
AI biomarkers in serious diseases | Serving Fibresolve, the first FDA-authorized AI diagnostic tool in ILD and IPF
About us
IMVARIA is advancing noninvasive AI biomarkers for better patient lives. We bring artificial intelligence to imaging and lab data, re-imagining clinical assessments in serious diseases. IMVARIA serves Fibresolve -- the first AI diagnostic tool in interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF). Fibresolve is an FDA Breakthrough Device and is authorized by the FDA to serve as an adjunctive, non-invasive diagnostic tool for patients with suspected ILD and IPF. Beyond ILD and IPF, IMVARIA is developing AI biomarkers in multiple areas including oncology, pulmonology, immunology, and more.
- Website
-
https://www.imvaria.com
External link for IMVARIA
- Industry
- Medical and Diagnostic Laboratories
- Company size
- 11-50 employees
- Headquarters
- Berkeley, CA
- Type
- Privately Held
- Founded
- 2019
- Specialties
- machine learning, medicine, data science, pulmonary, biopharma, clinical research, renal, hepatic, artificial intelligence, digital biomarkers, IPF, ILD, lung fibrosis, and Fibresolve
Locations
-
Primary
Get directions
Berkeley, CA 94705, US
-
Get directions
Carrollton, TX 75006, US